DJIA 18,053.71 23.50 0.13%
NASDAQ 4,806.86 33.39 0.70%
S&P 500 2,088.77 6.89 0.33%
market minute promo


company name or ticker

Belviq Weekly Sales Come In Flat

Belviq For Smoking Cessation - Sizzle Or Smolder?

Arena Pharmaceuticals (ARNA) Shares March Higher, Can It Continue? - Tale of the Tape

Arena Pharmaceuticals (ARNA) Shares March Higher, Can It Continue? - Tale of the Tape

What's Driving Orexigen Therapeutics Higher?

Arena Pharmaceuticals' (ARNA) Presents at Credit Suisse Healthcare Conference (Transcript)

Bel-Phen Pilot Study News, Hold On To Your Shares

Can Arena Pharmaceuticals Inc. Overcome Belviq's Slow Launch?

Arena Pharmaceuticals stock has fallen hard after a slower than expected launch of its fat-fighting pill Belviq. During its third-quarter conference call, though, management gave three reasons investors should be optimistic moving forward.

Why Orexigen Therapeutics, Inc. Stock Skyrocketed

Orexigen Therapeutics is today's best biotech stock after reporting its third-quarter earnings results and providing an update on its Contrave program. Find out if its shares can motor even higher.

Arena And Vivus Investors Need To Watch Orexigen

Belviq Sales Dip Slightly - Quarter Is Flat Thus Far

See More Articles...